Correlation Between Israel China and Panaxia Labs

Can any of the company-specific risk be diversified away by investing in both Israel China and Panaxia Labs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Israel China and Panaxia Labs into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Israel China Biotechnology and Panaxia Labs Israel, you can compare the effects of market volatilities on Israel China and Panaxia Labs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Israel China with a short position of Panaxia Labs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Israel China and Panaxia Labs.

Diversification Opportunities for Israel China and Panaxia Labs

0.1

Correlation Coefficient

Israel China  Panaxia Labs

Average diversification

The 3 months correlation between Israel and Panaxia is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding Israel China Biotechnology and Panaxia Labs Israel in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Panaxia Labs Israel and Israel China is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Israel China Biotechnology are associated (or correlated) with Panaxia Labs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Panaxia Labs Israel has no effect on the direction of Israel China i.e., Israel China and Panaxia Labs go up and down completely randomly.

Pair Corralation between Israel China and Panaxia Labs

Assuming the 90 days trading horizon Israel China Biotechnology is expected to under-perform the Panaxia Labs. But the stock apears to be less risky and, when comparing its historical volatility, Israel China Biotechnology is 1.0 times less risky than Panaxia Labs. The stock trades about -0.04 of its potential returns per unit of risk. The Panaxia Labs Israel is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  509,900  in Panaxia Labs Israel on September 27, 2024 and sell it today you would earn a total of  37,200  from holding Panaxia Labs Israel or generate 7.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Israel China Biotechnology  vs.  Panaxia Labs Israel

Israel China Biotech

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Israel China Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's fundamental drivers remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Panaxia Labs Israel

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Panaxia Labs Israel are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Panaxia Labs sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Israel China and Panaxia Labs

The main advantage of trading using opposite Israel China and Panaxia Labs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Israel China position performs unexpectedly, Panaxia Labs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Panaxia Labs will offset losses from the drop in Panaxia Labs' long position.

The idea behind Israel China Biotechnology and Panaxia Labs Israel pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.